http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab153bd85de31a9ea054365d0d943cbe
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Radice |
| name | Paolo Radice |
| given-name | Paolo |
| organization-name | Authors' Affiliations: Departments of 1Laboratory Medicine and Pathology, 2Health Sciences Research, and 3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; 4Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, California; 5Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; 6Centre Familial Breast and Ovarian Cancer, Department of Obstetrics and Gynecology and Centre for Integrated Oncology, University of Cologne, Cologne, Germany; 7Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 8IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; 9Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; 10Departments of Human Genetics and Medicine, McGill University and The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; 11Department of Health Science Research, Ophthalmology Department, Circolo and Fondazione Macchi Hospital, ASST Sette Laghi, Varese, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy60IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Research Department Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy 3Department of Experimental Oncology,; 6Istituto Nazionale per lo Studio e la Cura dei Tumori, and Federazione Italiana Ricerca Cancro, Institute of Molecular Oncology, Milan, Italy Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation... Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research Fondazione IRCCS Istituto Nazionale Tumori (INT) Milan Italy Ophthalmology Department, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, 21100 Varese, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy 3Dipartimento di Oncologia Sperimentale, Istituto Nazionale Tumori;; 4Istituto Fondazione Italiana per la Ricerca sul Cancro di Oncologia Molecolare, Milan, Italy; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine National Cancer Institute INT Milan Italy Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, 20133, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. Department of Ophthalmology, VR Division, Circolo and Macchi Foundation Hospital, ASST-Settelaghi, Varese, Italy; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Fondazione Istituto Neurologico Carlo Besta, 20133 Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy Ophtalmology Unit, ASST Sette Laghi, Varese, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy; FIRC Institute of Molecular Oncology Foundation Milano Italy 15Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori and IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori “Predictive Medicine: Molecular Bases of Genetic Risk” Milan Italy 8Department of Experimental Oncology Istituto Nazionale Tumori, Milan, Italy; Ophthalmology Department, Fatebenefratelli-Oftalmico Hospital, ASST-Fatebenefratelli-Sacco, Milan, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. 4Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Laboratories, Istituto Nazionale Tumori, and; 5Federazione Italiana Ricerca sul Cancro Institute of Molecular Oncology Foundation, Milan, Italy (Division of Experimental Oncology A - Istituto Nazionale Tumori, Milan) Unit of Molecular Bases of Genetic Risk and Genetic Testing, and; Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy Ospedale Fatebenefratelli-Oftalmico, Corso di Porta Nuova 23, Milan, Italy Fondazione IRCCS Istituto Nazionale dei Tumori (INT) Department of Experimental Oncology, Cancer Susceptibility Unit, Istituto Nazionale Tumori, Milan, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori (INT) Milan Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, and 2Department of Experimental Oncology,; 5IFOM, FIRC Institute of Molecular Oncology, Milan, Italy Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Molecular Medicine, IRCCS Foundation, National Cancer Institute, Milan; FIRC Institute of Molecular Oncology Foundation (IFOM), Milan The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Molecular Bases of Genetic Risk and Genetic Testing Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori (INT), Milan, Italy. Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy Division of Experimental Oncology A, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Aviano, Italy 74 Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine and Ospedale Fatebenefratelli e Oftalmico, Milan - Italy Division of Experimental Oncology A, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano Authors' Affiliations: 1Molecular Bases of Genetic Risk and Genetic Testing Unit, Department of Preventive and Predictive Medicine; 2Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 3The Roslin Institute, University of Edinburgh, Easter Bush Campus, Midlothian, United Kingdom; 4Institute of Child Health, University College London, London, United Kingdom Unit of Molecular Bases of Genetic Risk and Genetic Testing; Department of Research; Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale Tumori (INT); Milan Italy Istituto Nazionale Tumori, *Fondazione Italia per la Ricerca sul Cancro, Institute of Molecular Oncology, Milan, Italy 7Department of Experimental Oncology, Istituto Nazionale Tumori;; 8Fondazione Italiana per la Ricerca sul Cancro, Institute of Molecular Oncology, Milan, Italy; Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, Unit of Molecular Basis of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 147Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, in Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; IFOM Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy and. Unit of Molecular Bases of Genetic Risk and Genetic Testing; Department of Research; Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT); Milan Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predicted Medicine; Fondazione IRCCS Istituto Nazionale dei Tumouri (INT); Milan; Italy Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm; Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione Istituto Di Ricovero e Cura a Carattere, Scientifico, Istituto Nazionale Tumori, Milan, Italy From the Department of Oncology and Surgical Sciences, Oncology Section; Istituto Oncologico Veneto - IRCCS, Padua; U.O.A. ULSS 5 Ovest Vicentino, Vinicenza; Fondazione IRCCS Istituto Nazionale Tumori; FIRC Institute of Molecular Oncology Foundation; and the European Institute of Oncology, Milan, Italy 20Experimental Oncology and Molecular Bases of Genetic Risk and Genetic Testing Unit, Department of Preventive and Predictive Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 20Fondazione IRCCS Istituto Nazionale Tumori and IFOM Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; and Authors' Affiliations: 1Department of Experimental Therapeutics and the Center for RNA Interference and Non-coding RNAs and 2Division of Quantitative Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Li Ka Shing Institute of Health Sciences, Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China; 4Center for Systems and Computational Biology, Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; 5Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 6University of Ljubljana, Biotechnical Faculty Department of Animal Science, Domzale, Slovenia; and 7Unit of Medical Genetics and 8Hormone Research Laboratory, Department of Preventive and Predictive Medicine, 9Immunohematology and Transfusion Medicine Service, Department of Diagnostic Pathology and Laboratories, 10Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Molecular Medicine, Fonda; Authors' Affiliations: 1Department of Experimental Therapeutics and the Center for RNA Interference and Non-coding RNAs and 2Division of Quantitative Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Li Ka Shing Institute of Health Sciences, Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China; 4Center for Systems and Computational Biology, Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; 5Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 6University of Ljubljana, Biotechnical Faculty Department of Animal Science, Domzale, Slovenia; and 7Unit of Medical Genetics and 8Hormone Research Laboratory, Department of Preventive and Predictive Medicine, 9Immunohematology and Transfusion Medicine Service, Department of Diagnostic Pathology and Laboratories, 10Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Molecular Medicine, Fonda Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy Divisione di Oncologia Sperimentale A, Istituto Nazionale Tumori, Milano Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. 5Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori and FIRC Institute of Molecular Oncology, Milan, Italy; and Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine and Unit of Molecular Bases of Genetic Risk and Genetic Testing; Department of Research; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano; Milan Italy Unit of Molecular Bases of Genetic Risk & Genetic Testing, Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 2Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. Molecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy U.O.C. Oculistica, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy |
Incoming Links
Total number of triples: 381.